ACTRN12605000683639已完成3 期
se of exhaled nitric oxide levels in predicting response to oral steroids in patients with COPD
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Patients with COPDFEV1 <70% predicted, FEV1/FVC ratio <70%Smoker or ex-smoker of at least 20 pack years.
排除标准
- •Acute exacerbation within the last 3 months, patients receiving long-term oxygen treatment.
研究者
相似试验
招募中
不适用
Clinical Application of exhaled Nitric Oxide measurements in PrimarY careAsthmaRespiratory - AsthmaACTRN12605000354684niversity of Otago200
Unknown
不适用
The Value of FeNO in Predicting Airway Eosinophilic InflammationBiomarkersAirway InflammationNCT04885738The First Affiliated Hospital of Guangzhou Medical University2,052
已完成
不适用
Exhaled Nitric Oxide : Biomarker of Acute Respiratory Distress SyndromeARDS, HumanNitric OxydeNCT06250348University Hospital, Grenoble20
已完成
不适用
Phase II Evaluation of Exhaled Nitric Oxide (NO)Lung CancerNCT01392144M.D. Anderson Cancer Center36
已完成
不适用
Can monitoring exhaled nitric oxide levels in outpatients improve the management of children with asthma?AsthmaRespiratoryISRCTN50872816niversity of Southampton (UK)93